Selective Laser Trabeculoplasty (SLT)
Selective Laser Trabeculoplasty, or SLT, is a form of laser surgery that is used to lower intraocular pressure in glaucoma.
Who is a candidate for SLT?
Patients who have open-angle glaucoma (the drainage system in the front part of the eye is open) and need to lower their intraocular pressure (IOP) are eligible for the procedure. Your eye doctor will determine if you are a candidate.
How does it work?
Laser energy is applied to the drainage tissue in the eye. This starts a chemical and biological change in the tissue, resulting in better drainage of fluid through the drain and out of the eye. This eventually results in lowering of IOP. It may take 1-3 months for the results to appear.
Why is it called Selective?
The type of laser used has minimal heat energy absorption because it is only taken up by selective pigmented tissue in the eye. Sometimes it is referred to as a “cold laser.” Because of this, the procedure produces less scar tissue and has minimal pain.
What are the risks?
One key aspect of SLT is a favorable side effect profile, even when compared with glaucoma medications. Post-operative inflammation is common but generally mild, and treated with observation, eye drops or an oral non-steroidal anti-inflammatory drug. There is approximately a 5% incidence of IOP elevation after laser, which can be managed by glaucoma medications and usually goes away after 24 hours.
How effective is it?
SLT lowers the IOP by about 30% when used as initial therapy. This is comparable to the IOP lowering of the most powerful and commonly used class of glaucoma medication (prostaglandin analogs). This effect may be reduced if the patient is already on glaucoma medications.
How long does the effect last?
The effect will generally last between 1-5 years, and in rare cases, longer than that. If it does not last at least 6-12 months, it is usually not considered successful.
What happens if it wears off?
If SLT is effective at lowering IOP, once it wears off over several years, the procedure can be repeated. The second treatment may not be as effective as the first and may not last as long. If SLT is not initially successful, repeat treatment is not likely to be effective. Alternatively, glaucoma medication can be used if the effects wears off over time. 8. What happens if it doesn’t work? If SLT fails to lower the IOP, then the glaucoma is treated by other means such as medications or conventional surgery. The laser does not affect the success of these other types of treatment.
Will I still need to use glaucoma medications?
Some patients can be controlled with just laser treatment. Others require additional IOP lowering and may therefore need to use glaucoma medication as well. Think of the SLT as equivalent to one glaucoma medication. Just as some patients will require more than one glaucoma medication to control their IOP, some may also require laser plus one or more glaucoma medications. It is important to remember that SLT is not a cure for glaucoma, just as medication and surgery are not. Whatever method is used to treat glaucoma, appropriate follow up and testing with your eye care professional is critical.
Schedule your Glaucoma Evaluation today
Call (727) 581-8706 to schedule your appointment
Meet Your Glaucoma Care Specialists
Jeffrey S. Schwartz, MD is the first full-time board-certified, fellowship-trained glaucoma specialist in Pinellas County. He has been with The Eye Institute since 1988. His practice is limited to diagnosis, treatment, laser therapy and surgery of patients with glaucoma and other related diseases. Dr. Schwartz completed his residency at The University of South Florida and his glaucoma fellowship at the prestigious Jules Stein Eye Institute at UCLA. He is active in medical research and has made major contributions to the treatment and management of glaucoma. Dr. Schwartz is certified by the American Board of Ophthalmology, He serves as the medical consultant to pharmaceutical companies in the search for more effective glaucoma medications. Dr. Schwartz is on the Board of Directors and is the Medical Consultant for the Lighthouse of Pinellas and has served as the Medical Director for a number of health care plans.
Amy Z. Martino, MD completed her glaucoma fellowship at the world-renowned Bascom Palmer Eye Institute of the University of Miami Health System and School of Medicine, the #1 eye hospital and vision research center in the country. She was the first doctor in Hillsborough County to implant the Hydrus microstent for glaucoma and one of the first surgeons in Florida selected to implant the glaucoma iStent® device, the world’s smallest medical implant. Her surgical talents include glaucoma lasers and specialized glaucoma surgeries (such as trabeculectomies and glaucoma drainage devices). Dr. Martino is also a staff physician at the James A. Haley Veterans Hospital in Tampa, where she takes pride in serving those who have served our country. As a graduate of the University of South Florida, she enjoys giving lectures to the current ophthalmology residents. She volunteers her time through the Eye Care America program and Catholic Charities Medical Missions to help underprivileged patients receive eye care.
R. Taylor Davis, MD a Florida native with generational ties to Tampa Bay, started his medical education at The University of Florida. He graduated Cum Laude with a dual degree in Microbiology and Cell Science. During college, he was involved in 3 years of clinical research at the renowned Diabetes Center of Excellence. He received a master’s degree in Pharmacology at Tulane School of Medicine and was a primary investigator in cancer research under Dr. Debaisis Mondal. He attended medical school at Florida Atlantic University. After medical school, he completed his residency program at the LSU Department of Ophthalmology in New Orleans. During his residency, Dr. Davis remained active in research and presented his findings at many ophthalmology conferences across the United States. Through his research and residency training, he discovered his passion for treating patients with Glaucoma. Dr. Davis then completed two additional years of specialized fellowship-training at the prestigious UT Southwestern Hospital in Dallas, TX, where he diagnosed and treated a high volume of patients with complex Glaucoma problems. Dr. Davis is an active member of the American Academy of Ophthalmology, and the American Glaucoma Society. In his free time he enjoys traveling, boating, working out, diving, skiing, and spending time with friends and family.